KLF6 and cancer: In further agreement with our hypothesis that regulation of nucleo-cytoplasmic transport is a critical determinant of KLF6 function, we demonstrated that mutations in the KLF6 NLS domain result in decreased transcriptional activation of two cancer-relevant targets, p21 and E-cadherin.